• Home
  • About
    • Our Team
    • Our Partners
  • Our Work
  • Tools
    • Case Definitions
    • Vaccine Safety Templates
    • Translations
  • Resources
    • DSMB Training
    • News
    • Webinars
    • Vaccine Safety Quarterly
    • Safety by Numbers
  • CDC Training​
  • Join
  • SPEAC
Menu
  • Home
  • About
    • Our Team
    • Our Partners
  • Our Work
  • Tools
    • Case Definitions
    • Vaccine Safety Templates
    • Translations
  • Resources
    • DSMB Training
    • News
    • Webinars
    • Vaccine Safety Quarterly
    • Safety by Numbers
  • CDC Training​
  • Join
  • SPEAC
Posted on March 13, 2007September 14, 2023

Eczema vaccinatum as an adverse event following exposure to vaccinia virus

Adverse events following exposure to vaccinia virus: Following a declaration by The World Health Assembly in 1980 on the worldw...
Read More

Recent Posts

  • Template protocol for clinical trials investigating vaccines—Focus on safety elementsNovember 21, 2023
  • Safety Platform for Emergency vACcines (SPEAC)November 13, 2023
  • The next generation of pharmacovigilanceNovember 9, 2023
  • Safety by Numbers – October 2023November 8, 2023
  • Request for Review: TTS-VITT Draft Brighton Case DefinitionOctober 31, 2023

Email:
bc-coordinator@taskforce.org

Address:
The Task Force for Global Health,
330 W. Ponce de Leon Ave.
Decatur, GA 30030

  • Case Definitions
  • Safety Templates
  • Covid-19
  • Trusted Sources

© Brighton Collaboration  2023. All rights reserved.

  • Disclaimer and Privacy Policy